Initial investigation on the feasibility of porcine red blood cells from genetically modified pigs as an alternative to human red blood cells for transfusion.

Park, Sangkeun; Lee, Haneulnari; Park, Eun Mi; Roh, Juhye; Kang, Pul Ip; Shim, Joohyun; Choi, Kimyung; Kang, Hee Jung

Park, Sangkeun; Lee, Haneulnari; Park, Eun Mi; Roh, Juhye; Kang, Pul Ip; Shim, Joohyun; Choi, Kimyung; Kang, Hee Jung.

Afiliação

Park S; Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Lee H; Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Park EM; Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Roh J; Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Kang PI; Department of Transgenic Animal Research, Optipharm Inc., Cheongju, Republic of Korea.
Shim J; Department of Transgenic Animal Research, Optipharm Inc., Cheongju, Republic of Korea.
Choi K; Department of Transgenic Animal Research, Optipharm Inc., Cheongju, Republic of Korea.
Kang HJ; Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.

Front Immunol ; 14: 1298035, 2023.

Article em En | MEDLINE | ID: mdl-38035112

Assuntos

Eritrócitos; Hemólise; Animais; Humanos; Suínos; Animais Geneticamente Modificados; Estudos de Viabilidade; Haplorrinos

Palavras-chave

CD55; complement activation; genetically modified pigs; hemolysis; red blood cells; transfusion

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eritrócitos / Hemólise Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google